ABEO - Abeona Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

ABEO is currently covered by 5 analysts with an average price target of $21.6. This is a potential upside of $19.18 (792.56%) from yesterday's end of day stock price of $2.42.

Our record on ABEO covers 18 analysts since 2008; 5 cover it today. Of the 75 price targets those analysts set on ABEO, 19 were reached (25%). The highest performance score on ABEO belongs to Kristen Kluska of Cantor Fitzgerald: 36.59, with 1 of 6 targets met in 1 days on average. The latest calls: Raghuram Selvaraju of H.C. Wainwright cut the target to $18 from $20 with a Buy rating on 12 Nov 2026; Kristen Kluska of Cantor Fitzgerald raised the target to $30 from $28 with a Buy rating on 18 Sep 2026; Jeff Jones of Oppenheimer cut the target to $21 from $22 with a Buy rating on 14 Aug 2026. Figures as of 18 Nov 2026.

Abeona Therapeutics's activity chart (see below) currently has 75 price targets and 79 ratings on display. The stock rating distribution of ABEO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 26.41% of the time, taking 84.06 days on average.

Highest price target for ABEO is $30, Lowest price target is $17, average price target is $21.6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 12-Nov-2026. First documented stock forecast 05-Oct-2016.

Currently out of the existing stock ratings of ABEO, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-Oct-2017

$18

$15.58 (643.80%)

$20

10 days ago
(12-Nov-2026)

0/21 (0%)

$15.71 (686.03%)

Buy Since 08-Nov-2022

$30

$27.58 (1139.67%)

$28

2 months 4 days ago
(18-Sep-2026)

1/8 (12.5%)

$24.43 (438.60%)

1

Buy Since 17-Mar-2026

$21

$18.58 (767.77%)

$22

3 months 8 days ago
(14-Aug-2026)

0/2 (0%)

$15.01 (250.58%)

Buy Since 29-Apr-2025

$17

$14.58 (602.48%)

$19

8 months 5 days ago
(17-Mar-2026)

0/4 (0%)

$12.24 (257.14%)

Buy Since 02-Jun-2025

$22

$19.58 (809.09%)

$20

8 months 13 days ago
(09-Mar-2026)

0/3 (0%)

$16.84 (326.36%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABEO (Abeona Therapeutics) average time for price targets to be met?

On average it took 84 days for the stock forecasts to be reached, with an average price target met ratio of 26.41%.

Which analyst most recently updated their price target on ABEO (Abeona Therapeutics)?

Raghuram Selvaraju

Which analyst has the most public recommendations on ABEO (Abeona Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 12 price targets and 12 ratings on ABEO

Which analyst is the currently most bullish on ABEO (Abeona Therapeutics)?

Edward Nash with the highest potential upside of $572.58

Which analyst is the currently most reserved on ABEO (Abeona Therapeutics)?

Mani Foroohar with the lowest potential downside of $3.58
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?